Ditchcarbon
  • Contact
  1. Organizations
  2. I-Flow, LLC
Public Profile
Medical Device Manufacturing
US
updated a month ago

I-Flow, LLC Sustainability Profile

Company website

I-Flow, LLC, a prominent player in the medical device industry, is headquartered in the United States. Founded in 2001, the company has established itself as a leader in innovative pain management solutions, particularly in the field of regional anaesthesia and post-operative pain control. I-Flow is renowned for its advanced infusion systems, including the ON-Q Pain Relief System, which offers unique, patient-controlled analgesia options that enhance recovery experiences. With a commitment to quality and innovation, I-Flow has achieved significant milestones, including numerous patents and recognitions within the healthcare sector. Operating primarily in North America, I-Flow continues to expand its market presence, providing healthcare professionals with effective tools to improve patient outcomes. The company’s dedication to excellence positions it as a trusted partner in pain management solutions.

DitchCarbon Score

How does I-Flow, LLC's carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.

64

Industry Average

Mean score of companies in the Medical Device Manufacturing industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.

27

Industry Benchmark

I-Flow, LLC's score of 64 is higher than 80% of the industry. This can give you a sense of how well the company is doing compared to its peers.

80%

Let us know if this data was useful to you

I-Flow, LLC's reported carbon emissions

Inherited from Kimberly-Clark Corporation

I-Flow, LLC, headquartered in the US, currently does not report specific carbon emissions data, as no figures are available. However, the company is part of a corporate family that includes Kimberly-Clark Corporation, from which it inherits emissions data and climate commitments. As a current subsidiary of Kimberly-Clark Corporation, I-Flow, LLC aligns with the sustainability initiatives and reduction targets set by its parent company. Kimberly-Clark has established science-based targets (SBTi) aimed at reducing greenhouse gas emissions across its operations. These targets are cascaded down to I-Flow, ensuring that the subsidiary adheres to industry-standard climate commitments. While specific reduction targets for I-Flow, LLC are not detailed, the overarching goals from Kimberly-Clark reflect a commitment to sustainability and climate action. The company is actively engaged in initiatives to reduce its carbon footprint, although specific metrics and achievements for I-Flow are not disclosed. In summary, while I-Flow, LLC does not provide individual emissions data, it is committed to the climate goals set forth by Kimberly-Clark Corporation, focusing on reducing emissions and promoting sustainability within its operations.

Unlock detailed emissions data

Access structured emissions data, company-specific emission factors, and source documents

200520062007201520162017201820192020202120222023
Scope 1
2,600,000,000
0,000,000,000
0,000,000,000
0,000,000,000
0,000,000,000
0,000,000,000
0,000,000,000
0,000,000,000
0,000,000,000
0,000,000,000
0,000,000,000
0,000,000,000
Scope 2
3,000,000,000
0,000,000,000
0,000,000,000
0,000,000,000
0,000,000,000
0,000,000,000
0,000,000,000
0,000,000,000
0,000,000,000
0,000,000,000
0,000,000,000
0,000,000,000
Scope 3
-
-
-
00,000,000,000
00,000,000,000
00,000,000,000
00,000,000,000
00,000,000,000
00,000,000,000
00,000,000,000
00,000,000,000
00,000,000,000

How Carbon Intensive is I-Flow, LLC's Industry?

Very low
Low
Medium
High
Very high
Some industries are more carbon intensive than others. I-Flow, LLC's primary industry is Medical, precision and optical instruments, watches and clocks (33), which is very low in terms of carbon intensity compared to other industries.

How Carbon Intensive is I-Flow, LLC's Location?

Very low
Low
Medium
High
Very high
The carbon intensity of the energy grid powering a company's primary operations has a strong influence on its overall carbon footprint. This request for I-Flow, LLC is in US, which has a low grid carbon intensity relative to other regions.

I-Flow, LLC's Scope 3 Categories Breakdown

I-Flow, LLC's Scope 3 emissions, which decreased by 9% last year and decreased by approximately 23% since 2015, demonstrating supply chain emissions tracking. Most of their carbon footprint comes from suppliers and value chain emissions, with Scope 3 emissions accounting for 78% of total emissions under the GHG Protocol, with "Purchased Goods and Services" being the largest emissions source at 58% of Scope 3 emissions.

Top Scope 3 Categories

2023
Purchased Goods and Services
58%
End-of-Life Treatment of Sold Products
16%
Fuel and Energy Related Activities
11%
Upstream Transportation & Distribution
8%
Investments
4%
Waste Generated in Operations
3%
Capital Goods
<1%
Business Travel
<1%
Employee Commuting
<1%

I-Flow, LLC's Climate Goals (2030 & 2050)

Climate goals typically focus on 2030 interim targets and 2050 net-zero commitments, aligned with global frameworks like the Paris Agreement and Science Based Targets initiative (SBTi) to ensure alignment with global climate goals.

I-Flow, LLC has not publicly committed to specific 2030 or 2050 climate goals through the major frameworks we track. Companies often set interim 2030 targets and long-term 2050 net-zero goals to demonstrate measurable progress toward decarbonization.

Science Based Targets Initiative
Carbon Disclosure Project
The Climate Pledge
UN Global Compact
RE 100
Climate Action 100
Race To Net Zero
Reduction Actions

Compare I-Flow, LLC's Emissions with Industry Peers

Pacira BioSciences

US
•
Pharmaceutical Preparation Manufacturing
Updated about 1 month ago

Alkermes

IE
•
Pharmaceutical Preparation Manufacturing
Updated 9 days ago

Collegium Pharmaceutical, Inc.

US
•
Pharmaceutical Preparation Manufacturing
Updated about 1 month ago

Elite Pharmaceuticals, Inc.

US
•
Pharmaceutical Preparation Manufacturing
Updated 18 days ago

Egalet A/S

DK
•
Financial intermediation services, except insurance and pension funding services (65)
Updated about 2 months ago

Cumberland Pharmaceuticals Inc.

US
•
Pharmaceutical Preparation Manufacturing
Updated 2 days ago

Let us know if this data was useful to you

Where does DitchCarbon data come from?

Discover our data-driven methodology for measuring corporate climate action and benchmarking against industry peers

Ditchcarbon
v251030.3
[email protected]+44 203 475 7875Ditch Carbon Ltd167-169 Great Portland StreetLondon W1W 5PF
UL Solutions verification badge
CDP logo
Gartner Cool Vendor 2025 badge
ProductPortalScope 3 Tool FunctionalityDataIntegrationsPricing
CustomersHaleonGrant ThorntonHikmaRead all stories
SolutionsProcurement teamsSustainability teamsPlatform ownersCarbon accountants
ResourcesCalculation MethodologyDocumentationBlogFAQOrganizationsIndustriesSBTI APITrust CentreChangelog
AboutTeamCareersLicense AgreementPrivacy